Report cover image

Global Human Vaccine Adjuvants Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 94 Pages
SKU # APRC20353673

Description

Summary

According to APO Research, The global Human Vaccine Adjuvants market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Human Vaccine Adjuvants is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Human Vaccine Adjuvants is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Human Vaccine Adjuvants is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Human Vaccine Adjuvants include GSK, Zhifei Biological, Escon, Sanofi, Rico Bio, Huanuotai Biological, SEPPIC, CSL Limited and Croda, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine Adjuvants.

The Human Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Human Vaccine Adjuvants Segment by Company

GSK
Zhifei Biological
Escon
Sanofi
Rico Bio
Huanuotai Biological
SEPPIC
CSL Limited
Croda

Human Vaccine Adjuvants Segment by Type

Aluminium Salt Adjuvant
Oil Emulsion Adjuvant
Others

Human Vaccine Adjuvants Segment by Application

Commercial
Research

Human Vaccine Adjuvants Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

94 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Vaccine Adjuvants Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Human Vaccine Adjuvants Sales Estimates and Forecasts (2020-2031)
1.3 Human Vaccine Adjuvants Market by Type
1.3.1 Aluminium Salt Adjuvant
1.3.2 Oil Emulsion Adjuvant
1.3.3 Others
1.4 Global Human Vaccine Adjuvants Market Size by Type
1.4.1 Global Human Vaccine Adjuvants Market Size Overview by Type (2020-2031)
1.4.2 Global Human Vaccine Adjuvants Historic Market Size Review by Type (2020-2025)
1.4.3 Global Human Vaccine Adjuvants Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
1.5.2 Europe Human Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Human Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
1.5.4 South America Human Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Human Vaccine Adjuvants Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Human Vaccine Adjuvants Industry Trends
2.2 Human Vaccine Adjuvants Industry Drivers
2.3 Human Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Human Vaccine Adjuvants Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Human Vaccine Adjuvants Revenue (2020-2025)
3.2 Global Top Players by Human Vaccine Adjuvants Sales (2020-2025)
3.3 Global Top Players by Human Vaccine Adjuvants Price (2020-2025)
3.4 Global Human Vaccine Adjuvants Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Human Vaccine Adjuvants Major Company Production Sites & Headquarters
3.6 Global Human Vaccine Adjuvants Company, Product Type & Application
3.7 Global Human Vaccine Adjuvants Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Human Vaccine Adjuvants Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Vaccine Adjuvants Players Market Share by Revenue in 2024
3.8.3 2023 Human Vaccine Adjuvants Tier 1, Tier 2, and Tier 3
4 Human Vaccine Adjuvants Regional Status and Outlook
4.1 Global Human Vaccine Adjuvants Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Human Vaccine Adjuvants Historic Market Size by Region
4.2.1 Global Human Vaccine Adjuvants Sales in Volume by Region (2020-2025)
4.2.2 Global Human Vaccine Adjuvants Sales in Value by Region (2020-2025)
4.2.3 Global Human Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Human Vaccine Adjuvants Forecasted Market Size by Region
4.3.1 Global Human Vaccine Adjuvants Sales in Volume by Region (2026-2031)
4.3.2 Global Human Vaccine Adjuvants Sales in Value by Region (2026-2031)
4.3.3 Global Human Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Human Vaccine Adjuvants by Application
5.1 Human Vaccine Adjuvants Market by Application
5.1.1 Commercial
5.1.2 Research
5.2 Global Human Vaccine Adjuvants Market Size by Application
5.2.1 Global Human Vaccine Adjuvants Market Size Overview by Application (2020-2031)
5.2.2 Global Human Vaccine Adjuvants Historic Market Size Review by Application (2020-2025)
5.2.3 Global Human Vaccine Adjuvants Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
5.3.2 Europe Human Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Human Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
5.3.4 South America Human Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Human Vaccine Adjuvants Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Human Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments
6.2 Zhifei Biological
6.2.1 Zhifei Biological Comapny Information
6.2.2 Zhifei Biological Business Overview
6.2.3 Zhifei Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zhifei Biological Human Vaccine Adjuvants Product Portfolio
6.2.5 Zhifei Biological Recent Developments
6.3 Escon
6.3.1 Escon Comapny Information
6.3.2 Escon Business Overview
6.3.3 Escon Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Escon Human Vaccine Adjuvants Product Portfolio
6.3.5 Escon Recent Developments
6.4 Sanofi
6.4.1 Sanofi Comapny Information
6.4.2 Sanofi Business Overview
6.4.3 Sanofi Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Human Vaccine Adjuvants Product Portfolio
6.4.5 Sanofi Recent Developments
6.5 Rico Bio
6.5.1 Rico Bio Comapny Information
6.5.2 Rico Bio Business Overview
6.5.3 Rico Bio Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Rico Bio Human Vaccine Adjuvants Product Portfolio
6.5.5 Rico Bio Recent Developments
6.6 Huanuotai Biological
6.6.1 Huanuotai Biological Comapny Information
6.6.2 Huanuotai Biological Business Overview
6.6.3 Huanuotai Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Huanuotai Biological Human Vaccine Adjuvants Product Portfolio
6.6.5 Huanuotai Biological Recent Developments
6.7 SEPPIC
6.7.1 SEPPIC Comapny Information
6.7.2 SEPPIC Business Overview
6.7.3 SEPPIC Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SEPPIC Human Vaccine Adjuvants Product Portfolio
6.7.5 SEPPIC Recent Developments
6.8 CSL Limited
6.8.1 CSL Limited Comapny Information
6.8.2 CSL Limited Business Overview
6.8.3 CSL Limited Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CSL Limited Human Vaccine Adjuvants Product Portfolio
6.8.5 CSL Limited Recent Developments
6.9 Croda
6.9.1 Croda Comapny Information
6.9.2 Croda Business Overview
6.9.3 Croda Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Croda Human Vaccine Adjuvants Product Portfolio
6.9.5 Croda Recent Developments
7 North America by Country
7.1 North America Human Vaccine Adjuvants Sales by Country
7.1.1 North America Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Human Vaccine Adjuvants Sales by Country (2020-2025)
7.1.3 North America Human Vaccine Adjuvants Sales Forecast by Country (2026-2031)
7.2 North America Human Vaccine Adjuvants Market Size by Country
7.2.1 North America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Human Vaccine Adjuvants Market Size by Country (2020-2025)
7.2.3 North America Human Vaccine Adjuvants Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Human Vaccine Adjuvants Sales by Country
8.1.1 Europe Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Human Vaccine Adjuvants Sales by Country (2020-2025)
8.1.3 Europe Human Vaccine Adjuvants Sales Forecast by Country (2026-2031)
8.2 Europe Human Vaccine Adjuvants Market Size by Country
8.2.1 Europe Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Human Vaccine Adjuvants Market Size by Country (2020-2025)
8.2.3 Europe Human Vaccine Adjuvants Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Human Vaccine Adjuvants Sales by Country
9.1.1 Asia-Pacific Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Human Vaccine Adjuvants Sales by Country (2020-2025)
9.1.3 Asia-Pacific Human Vaccine Adjuvants Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Human Vaccine Adjuvants Market Size by Country
9.2.1 Asia-Pacific Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Human Vaccine Adjuvants Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Human Vaccine Adjuvants Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Human Vaccine Adjuvants Sales by Country
10.1.1 South America Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Human Vaccine Adjuvants Sales by Country (2020-2025)
10.1.3 South America Human Vaccine Adjuvants Sales Forecast by Country (2026-2031)
10.2 South America Human Vaccine Adjuvants Market Size by Country
10.2.1 South America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Human Vaccine Adjuvants Market Size by Country (2020-2025)
10.2.3 South America Human Vaccine Adjuvants Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Human Vaccine Adjuvants Sales by Country
11.1.1 Middle East and Africa Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Human Vaccine Adjuvants Sales by Country (2020-2025)
11.1.3 Middle East and Africa Human Vaccine Adjuvants Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Human Vaccine Adjuvants Market Size by Country
11.2.1 Middle East and Africa Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Human Vaccine Adjuvants Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Human Vaccine Adjuvants Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Human Vaccine Adjuvants Value Chain Analysis
12.1.1 Human Vaccine Adjuvants Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Vaccine Adjuvants Production Mode & Process
12.2 Human Vaccine Adjuvants Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Vaccine Adjuvants Distributors
12.2.3 Human Vaccine Adjuvants Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.